Libo Pharma Corp. (TPEX:7888)
Taiwan · Delayed Price · Currency is TWD 30.00
0.00 (0.00%)
At close: Jul 9, 2026
Libo Pharma Market Cap
Libo Pharma has a market cap or net worth of 2.26 billion as of July 9, 2026.
Market Cap
2.26B
Enterprise Value
1.46B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
30.00
Market Cap Chart
Since December 23, 2025, Libo Pharma's market cap has decreased from 3.55B to 2.26B, a decrease of -36.37%. That is a compound annual growth rate of -56.55%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 9, 2026 | 2.26B | -39.02% |
| Dec 31, 2025 | 3.70B | 4.35% |
| Dec 23, 2025 | 3.55B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TCM Biotech International | 15.83B |
| Pharmasaga | 12.74B |
| Taho Pharmaceuticals | 6.02B |
| TEH SENG Pharmaceutical Mfg. | 2.16B |
| Anbogen Therapeutics | 2.06B |
| Timing Pharmaceutial | 1.73B |
| TSA International | 1.60B |
| Anya Biopharm | 1.60B |